Mònica Vall-Palomar

Mònica Vall-Palomar

Auto-generated profile, based on publicly available information

Mònica Vall-Palomar

Renal Physiopathology Group, Vall d’Hebron Research Institute, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2021 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
MVMònica Vall-Palomar
Mònica Vall-Palomar
LMLeire Madariaga
Leire Madariaga
GAGema Ariceta
Gema Ariceta

9 November 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JAJazmine Arevalo
Jazmine Arevalo
ICI. Campoy
I. Campoy
MDM. Durán
M. Durán
SNStéphane Nemours
Stéphane Nemours
AAA. Areny
A. Areny
ANAnna Meseguer Navarro
Anna Meseguer Navarro
The signal transducer and activator of transcription 3 (STAT3) is a transcription factor mainly activated by phosphorylation in either tyrosine 705 (Y705) or serine 727 (S727) residues that regulates essential processes such as cell differentiation, apoptosis inhibition, or cell survival. Aberrant activation of STAT3 has been related to development of nearly 50% of human cancers including clear cell renal cell carcinoma (ccRCC). In fact, phosho-S727 (pS727) levels correlate with overall survival of ccRCC patients. With the aim to elucidate the contribution of STAT3 phosphorylation in ccRCC development and progression, we have generated human-derived ccRCC cell lines carrying STAT3 Y705 and S727 phosphomutants. Our data show that the phosphomimetic substitution Ser727Asp facilitates a pro-tumoral phenotype in vitro,in a Y705-phosphorylation-independent manner. Moreover, we describe that STAT3 phosphorylation state determines the expression of different subsets of target genes associated with distinct biological processes, being pS727-dependent genes the most related to cellular hallmarks of cancer. In summary, the present study constitutes the first analysis on the role of overall STAT3 phosphorylation state in ccRCC and demonstrates that pS727 promotes the expression of a specific subset of target genes that might be clinically relevant as novel biomarkers and potential therapeutic targets for ccRCC.

1 September 2020 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
AGAlejandro García‐Castaño
Alejandro García‐Castaño
APAna Perdomo-Ramirez
Ana Perdomo-Ramirez
MVMònica Vall‐Palomar
Mònica Vall‐Palomar
ERElena Ramos-Trujillo
Elena Ramos-Trujillo
LMLeire Madariaga
Leire Madariaga
FCFelix Claverie-Martin
Felix Claverie-Martin
Background: Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is an autosomal recessive tubulopathy characterized by excessive urinary wasting of magnesium and calcium, bilateral nephrocalcinosis, and progressive chronic renal failure in childhood or adolescence. FHHNC is caused by mutations in CLDN16 and CLDN19, which encode the tight‐junction proteins claudin‐16 and claudin‐19, respectively. Most of these mutations are missense mutations and large deletions are rare.Methods: We examined the clinical and biochemical features of a Spanish boy with early onset of FHHNC symptoms. Exons and flanking intronic segments of CLDN16 and CLDN19 were analyzed by direct sequencing. We developed a new assay based on Quantitative Multiplex PCR of Short Fluorescent Fragments (QMPSF) to investigate large CLDN16 deletions.Results: Genetic analysis revealed two novel compound heterozygous mutations of CLDN16, comprising a missense mutation, c.277G>A; p.(Ala93Thr), in one allele, and a gross deletion that lacked exons 4 and 5,c.(840+25_?)del, in the other allele. The patient inherited these variants from his mother and father, respectively.Conclusions: Using direct sequencing and our QMPSF assay, we identified the genetic cause of FHHNC in our patient. This QMPSF assay should facilitate the genetic diagnosis of FHHNC. Our study provided additional data on the genotypic spectrum of the CLDN16 gene.